在结直肠癌中,RAS基因突变和病理形态特征之间的相关性分析
Yifei Wang1, Lili Guo1, Chunxue Yang1
1Department of Pathology, Jilin Provincial Cancer Hospital, Changchun, 13000, China.
Scientific reports
|December 9, 2025
概括
结直肠癌的基因突变 (KRAS) 与瘤芽和粘膜成分等攻击性特征有关. KRAS突变与较长的整体存活率有关,但TNM阶段和差异化仍然是关键的不良预后因素.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题.
- 基尔斯大鼠肉瘤病毒瘤基因 (KRAS) 突变在CRC中很常见,并影响治疗决策.
- 了解KRAS突变与组织病理特征之间的联系对于预后至关重要.
研究的目的:
- 为了研究KRAS突变与结直肠癌中的组织病理特征之间的关联.
- 评估CRC患者中KRAS突变的预后影响.
- 探索KRAS突变状态和临床病理因素之间的关系.
主要方法:
- 对256名结直肠腺癌患者的回顾性分析.
- 使用ADx-ARMS套件检测大鼠肉瘤 (RAS) 基因突变 (KRAS和NRAS).
- 经验丰富的病理学家对瘤分化,粘膜成分和瘤芽的组织病理学评估.
- 使用后勤回归和考克斯比例危险模型进行统计分析.
主要成果:
- 在52.7%的患者中发现了KRAS突变,其中G12D,G13D,G12V和G12C是主要的亚型.
- 克拉斯突变独立预测了右侧结肠瘤,高瘤芽和粘膜成分.
- 与野生型KRAS相比,KRAS突变患者的整体存活时间 (OS) 更长.
- 第四阶段的TNM,差异化的差异化和缺乏初级瘤切除是独立的不良预后因素.
结论:
- KRAS突变与结直肠癌的侵袭性组织病理特征显著相关,包括瘤芽和粘膜分化.
- 组织病理学评估,以及KRAS突变状态,可以帮助CRC患者的风险分层.
- 临床实践中的预后评估应整合TNM分期和KRAS突变状态,以改善患者管理.
相关概念视频
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K


